A novel human liver-chimeric mouse model developed at Oregon Health & Science University and Yecuris Corporation has made possible a research breakthrough at Seattle Biomedical Research Institute that will greatly accelerate studies of the most lethal forms of human malaria. The study findings are published online in the Journal of Clinical Investigation. Study photos were selected to appear in “Scientific Show Stoppers” on the JCI blog.
